News

Filter

Current filters:

None

8020 to 8029 of 97551 results

Australian Productivity Commission reviews compulsory licensing in the patents system

30-08-2012

The Australian Productivity Commission's review into compulsory licensing in the patents system is now…

Asia-PacificBiotechnologyLicensingPatentsPharmaceutical

Lilly halts development of schizophrenia candidate pomaglumetad methionil

30-08-2012

US drug major Eli Lilly (NYSE: LLY) saw its shares dip less than 1% to $44.51 in morning trading yesterday,…

Eli LillyFinancialNeurologicalPharmaceuticalpomaglumetad methionilResearch

STEMI guidelines now recommend AstraZeneca's ticagrelor as first-line treatment option

30-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that ticagrelor, its oral antiplatelet…

AstraZenecaBrilintaBriliqueCardio-vascularEffientEli LillyPharmaceuticalRegulation

Hospira to acquire Orchid API production and R&D facility

30-08-2012

US injectable generic drugs specialist Hospira (NYSE: HSP) has reached an agreement to acquire an active…

GenericsHospiraMarkets & MarketingOrchid Chemicals & PharmaceuticalsProductionResearch

Lundbeck gets marketing OK for Treanda in Canada

29-08-2012

Danish CNS drug specialist Lundbeck A/S (LUND: DC) says that medicines regulator Health Canada has approved…

LundbeckNorth AmericaOncologyPharmaceuticalRegulationTreanda

Boehringer's Spiriva has advantages for patients with COPD, says IQWiG

29-08-2012

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD),…

Boehringer IngelheimEuropePharmaceuticalRegulationRespiratory and PulmonarySpiriva

QPS buys majority of Austria's largest independent CRO

29-08-2012

In a second European acquisition, USA-based QPS, a full-service GLP/GCP-compliant contract research organization,…

BiotechnologyJSW Life SciencesMarkets & MarketingPharmaceuticalQPS HoldingsResearch

8020 to 8029 of 97551 results

Back to top